S49076 (hydrochloride) is primarily investigated for its potential in cancer therapy, particularly as a targeted treatment for various types of tumors. It functions as a dual inhibitor of key signaling pathways involved in cancer cell growth and survival, making it a promising candidate for precision medicine. Its application is being studied in clinical trials to evaluate its efficacy in treating solid tumors and hematologic malignancies. Researchers are also exploring its potential in combination therapies to enhance overall treatment outcomes and overcome drug resistance in cancer patients.